Quick Facts
  • pin location icon
    Primary Location:
    National Institutes of Health
  • wavy circle icon with check mark inside
    Expertise:
    Clinical Trials
    Immunotherapy
  • magnifying glass with heart icon
    Speciality:
    Thoracic Oncology
  • gender symbols interlocked icon
    Gender:
    Male
  • chat box with different language translations icon
    Language:
    English
  • certificate with a ribbon icon below
    Med School:
    University of Connecticut School of Medicine

Dr. David Schrump was one of the key speakers at the 2011 International Symposium on Malignant Mesothelioma, sharing the podium with colleagues David Sugarbaker, M.D., Daniel Sterman, M.D., and Raffit Hassan, M.D.

Their topic was “Experimental Strategies in Malignant Mesothelioma,” which was directly related to several of Schrump’s recent clinical trials. At the time of the symposium, Schrump was the principal investigator for seven different trials studying patients with diseases such as lung cancer and malignant mesothelioma.

Contact Dr. David Schrump
medical stethoscope icon
By submitting, you agree to our privacy policy and disclaimer. Our Patient Advocates may contact you via phone, email and/or text.

Schrump has been in his current position since 1997 with tenure since 2006. He completed his general surgery residency at the University of Chicago, following his graduation from the University of Connecticut School of Medicine.

Quick Fact:
Dr. Schrump completed a three-year research fellowship exploring human cancer immunology at Memorial Sloan Kettering Cancer Center.

Schrump’s Publications

Schrump’s articles have included seven titles on mesothelioma, each discussing a different aspect of the chemotherapeutic treatment or genetic makeup of the cancer. These articles can be found in the Journal of Surgical Resection, Journal of Thoracic Cardiovascular Surgery, Clinical Cancer Research, and Anticancer Research.